Evidence map›Paper›PMID 24312838›Full record

ArticleAdvanced pharmaceutical bulletin2013

Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice.

Leili Aghebati Maleki, Jafar Majidi, Behzad Baradaran, Jalal Abdolalizadeh, Tohid Kazemi, Ali Aghebati Maleki, Koushan Sineh Sepehr

Open access · greenAbstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. A methodological approach for production and purification of polyclonal antibody against dog IgG.Veterinary research forum : an international quarterly journal · 2018
    Article
  7. Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G.Veterinary research forum : an international quarterly journal · 2017
    Article
  8. Overview of Albumin and Its Purification Methods.Advanced pharmaceutical bulletin · 2016
    Review
  9. Physicochemical Evaluation of Lyophilized Formulation ofIranian journal of pharmaceutical research : IJPR · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Leili Aghebati MalekiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ; Tabriz International University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. ; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz, Iran.
Jafar Majidi
Behzad Baradaran
Jalal Abdolalizadeh
Tohid Kazemi
Ali Aghebati Maleki
Koushan Sineh Sepehr
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMonoclonal antibodies or specific antibodies are now an essential tool of biomedical research and are of great commercial and medical value. The purpose of this study was to produce large scale of monoclonal antibody against CD34 in order to diagnostic application in leukemia and purification of human hematopoietic stem/progenitor cells.

methodsFor large scale production of monoclonal antibody, hybridoma cells that produce monoclonal antibody against human CD34 were injected into the peritoneum of the Balb/c mice which have previously been primed with 0.5 ml Pristane. 5 ml ascitic fluid was harvested from each mouse in two times. Evaluation of mAb titration was assessed by ELISA method. The ascitic fluid was examined for class and subclasses by ELISA mouse mAb isotyping Kit. mAb was purified from ascitic fluid by affinity chromatography on Protein A-Sepharose. Purity of monoclonal antibody was monitored by SDS -PAGE and the purified monoclonal antibody was conjugated with FITC.

resultsMonoclonal antibodies with high specificity and sensitivity against human CD34 by hybridoma technology were prepared. The subclass of antibody was IgG1 and its light chain was kappa.

conclusionThe conjugated monoclonal antibody could be a useful tool for isolation, purification and characterization of human hematopoietic stem cells.

Indexed as

Ascetic fluidHuman CD34Large Scale generationMonoclonal antibody

Identifiers

PMID24312838
PMCPMC3846064
OpenAlexW2125466256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.